Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: a randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
Su funcin es identificar a un usuario cuando ste introduzca sus credenciales al iniciar sesin
PMID 17067183
Have a BMI that is 30 or 35 with one or more previously diagnosed conditions: Controlled Type II Diabetes, Sleep Apnea, High Cholesterol, High Triglycerides, Prediabetes, High Blood Pressure, Heart disease, Osteoarthritis, Polycystic Ovarian Syndrome (PCOS), Non-alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease, Gastroesophageal Reflux Disease (GERD), Depression, Anxiety, Weight-Related Psychosocial Distress, Stroke, Coronary Artery Disease, Metabolic Syndrome, Insulin Resistance, Body Pain, Infertility, Hypothyroidism, Sexual Dysfunction
Secure & Smooth Buying: Quick checkout is available on the vendors state-of-the-art website, with customer data protected via advanced SSL encryption technology